|Bid||0.1250 x 0|
|Ask||0.1300 x 0|
|Day's range||0.1250 - 0.1350|
|52-week range||0.0320 - 0.1850|
|Beta (5Y monthly)||2.85|
|PE ratio (TTM)||N/A|
|Earnings date||27 Oct 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||1.16|
Rick Carreon has been the CEO of ImpediMed Limited (ASX:IPD) since 2012, and this article will examine the executive's...
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
ImpediMed Limited's (ASX:IPD): ImpediMed Limited, together with its subsidiaries, develops, manufactures, and sells...